Author (origin) Study design GDM screening 50 g GCT criteria 75 g OGTT criteria 100 g OGTT criteria Lapolla et al., 2011 (Italy) [31 ] Retrospective cohort Two-Step: 50 g 1 h; if >140 mg/dL: 100 g 3 h GTT ≥140 mg/dL: 100 g 3 h GTT Not done 2 abnormal values of fasting ≥ 95 mg/dL, or 1 h 180 mg/dl; 2 h 155 mg/dL; 3 h 140 mg/dL Bodmer-Roy et al., 2012 (Canada) [32 ] Retrospective cohort Two-Step: 50 g 1 h; if 137–184 mg/dL: 75 g 2 h GTT 137–184 mg/dL: 75 g GTT; >184 mg/dL: GDM 1 abnormal value of fasting ≥ 96 mg/dL; 1 h: ≥191 mg/dl; 2 h: ≥160 mg/dL Not done Benhalima et al., 2013 (Belgium) [33 ] Retrospective cohort Two-Step: 50 g 1 h; if ≥140 mg/dL:100 g 3 h GTT ≥140 mg/dL: 100 g 3 h GTT Not done 2 abnormal values of fasting ≥ 95 mg/dL, or 1 h 180 mg/dl; 2 h 155 mg/dL; 3 h 140 mg/dL Ethridge et al., 2014 (USA) [34 ] Retrospective cohort Two-Step: 50 g 1 h; if ≥135 mg/dL:100 g 3 h GTT ≥135 mg/dL: 100 g 3 h GTT Not done 2 abnormal values of fasting ≥ 95 mg/dL, or 1 h 180 mg/dl; 2 h 155 mg/dL; 3 h 140 mg/dL Liao et al., 2014 (China) [35 ] Retrospective cohort Two-Step: 50 g 1 h; if ≥140 mg/dL: 100 g 3 h GTT ≥140 mg/dL: 100 g 3 h GTT Not done 2 abnormal values of fasting ≥ 95 mg/dL, or 1 h 180 mg/dl; 2 h 155 mg/dL; 3 h 140 mg/dL Mayo et al., 2015 (Canada) [36 ] Retrospective cohort Two-Step: 50 g 1 h; if 140–184 mg/dL: 75 g 2 h GTT If 140–184 mg/dL: 75 g GTT; >184 mg/dL: GDM 1 abnormal value of fasting ≥ 95 mg/dL; 1 h: ≥191 mg/dl: 2 h: ≥160 mg/dL Not done Meek et al., 2015 (UK) [37 ] Retrospective cohort Two-Step: 50 g 1 h; if >138 mg/dL: 75 g 2 h GTT >138 mg/dL: 75 g 2 h GTT 1 abnormal value of fasting ≥ 110/128 mg/dL; 2 h: ≥140 mg/dL Not done Tward et al., 2016 (Canada) [38 ] Retrospective cohort Two-Step: 50 g 1 h; if >140 mg/dL: 75 g 2 h GTT ≥140 mg/dL: 75 g 2 h GTT 2 abnormal values of fasting ≥ 95 mg/dL; 1 h: ≥191 mg/dl: 2 h: ≥160 mg/dL Not done